Beta Bionics (BBNX) Institutional Ownership

Of the 118 institutional investors that purchased Beta Bionics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($4.99M), Wellington Management Group LLP ($3.90M), BlackRock Inc. ($3.34M), Sands Capital Ventures LLC ($3.10M), Omega Fund Management LLC ($1.99M), Vanguard Group Inc. ($1.51M), and Eversept Partners LP ($1.41M).

Institutional investors have bought a total of 16,871,009 shares in the last 24 months. This purchase volume represents approximately $357.99M in transactions.

Of the 22 institutional investors that sold Beta Bionics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Soleus Capital Management L.P. ($1.34M), RTW Investments LP ($799.19K), Healthcare of Ontario Pension Plan Trust Fund ($780.97K), Omega Fund Management LLC ($603.94K), Marshall Wace LLP ($387.01K), Morgan Stanley ($302.13K), and Bank of America Corp DE ($296.13K).

Institutional investors have sold a total of 5,050,946 shares in the last 24 months. This volume of shares sold represents approximately $125.94M in transactions.